Aspen Aerogels Inc

Aspen Aerogels has a market price of $5.82 and a market cap of $482.05 million, with a price-to-book ratio of 2.05 and a price-to-tangible-book ratio of 2.05. The company's enterprise value to revenue ratio is 1.64, while its enterprise value to EBITDA ratio is negative at -1.18, indicating a loss-making position. The company's debt-to-equity ratio is 0.51, and its current ratio is 3.9, suggesting strong short-term liquidity. The company's profitability metrics are weak, with a return on equity of -1.65 and a return on assets of -0.96. These figures are below the typical performance of the specialty chemicals industry, which generally expects positive returns on equity and assets. The company's operating income is negative at -$378.22 million, and its net income is also negative at -$389.55 million, indicating significant operational challenges. Aspen Aerogels generates revenue from its aerogel insulation products, with no disclosed segment breakdown. The company's geographic exposure is not specified in the available data, but its revenue concentration appears to be in the industrial and commercial markets. The company's revenue for the latest period is $271.10 million. The company's growth trajectory is uncertain, with no specific outlook provided for the current or next fiscal year. The company's free cash flow is negative at -$381.80 million, and its capital expenditure is -$37.45 million, indicating ongoing investment in operations despite losses. The company's operating cash flow is $32.87 million, which provides some liquidity but is insufficient to offset the net loss. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's dilution potential is low, and no adjustments have been applied to its valuation metrics. The company's risk score is not explicitly provided, but the absence of flags suggests a relatively stable capital structure. Recent events include analyst estimates with a mean price target of $4.20 and a median price target of $4.00. The mean recommendation is 2.50, indicating a "hold" rating, with four "buy" and one "hold" recommendation. No strong-buy recommendations were issued.